Key terms

About WVE

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest WVE news

Yesterday 1:44pm ET Wave Life Sciences management to meet virtually with Truist by TipRanks Apr 01 7:21am ET Analysts’ Top Healthcare Picks: Wave Life Sciences (WVE), Passage Bio (PASG) by TipRanks Apr 01 7:21am ET Truist Financial Reaffirms Their Buy Rating on Wave Life Sciences (WVE) by TipRanks Mar 12 6:41am ET Wave Life Sciences price target raised to $19 from $10 at Mizuho by TipRanks Mar 11 2:40am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Illumina (ILMN), MoonLake Immunotherapeutics (MLTX) and Wave Life Sciences (WVE) by TipRanks Mar 11 1:10am ET Analysts Are Bullish on These Healthcare Stocks: Wave Life Sciences (WVE), Dexcom (DXCM) by TipRanks Mar 07 9:31am ET Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), Brainsway (BWAY) and Wave Life Sciences (WVE) by TipRanks Mar 07 6:06am ET Wave Life Sciences price target raised to $15 from $8 at H.C. Wainwright by TipRanks Mar 06 7:52am ET Wave Life Sciences Unveils New Corporate Presentation by TipRanks Mar 06 7:33am ET Wave Life Sciences reports Q4 EPS (15c), consensus (23c) by TipRanks Feb 27 8:49am ET Wave Life Sciences announces upcoming presentations at MDA conference by TipRanks Feb 02 11:07am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 01 1:18am ET Strategic Investment Boosts Wave Life Sciences: A Buy Rating Amidst Market Underappreciation by TipRanks

No recent press releases are available for WVE

WVE Financials

1-year income & revenue

Key terms

WVE Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

WVE Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

A bubble tea store operated by Sichuan Baicha Baidao in Shanghai, China, on April 23, 2024.
Raul Ariano/Bloomberg/Getty Images
Is the tea bubble bursting? ChaPanda shares plunge in Hong Kong IPO
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Can markets make a comeback? That depends on tech earnings
People walk past the New York Stock Exchange Thursday, March. 21, 2024.
Yuki Iwamura/AP
Investors are fearful. They shouldn’t be
People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally